Cover Image
市場調查報告書

心臟再同步治療(CRT)設備:新興市場(巴西、俄羅斯、印度、中國、南非、韓國)

Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

出版商 Axis Research Mind 商品編碼 307373
出版日期 內容資訊 英文 476 Pages; 103 Tables/Charts
商品交期: 最快1-2個工作天內
價格
Back to Top
心臟再同步治療(CRT)設備:新興市場(巴西、俄羅斯、印度、中國、南非、韓國) Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
出版日期: 2014年06月30日 內容資訊: 英文 476 Pages; 103 Tables/Charts
簡介

BRICSS各國的新心臟再同步治療(CRT)設備市場中、銷售額幾乎分為兩部分的心再同步治療功能的內建除顫器(CRT-D)和心臟再同步治療心律調整器(CRT-P)為主力商品、2016年預測達4億5500萬美金的規模。各國構成比中、約25%的中國為首位緊接在後的事23%的印度、複合每年成長率也是由此兩國分站1、2位、持續在後的是韓國。醫療產業在過去3-5年間、隨技術創新有很大的轉變、心臟血管領域也因新素材及軟體等複合的進步、推動國際企業的產品強化及市場開發。

本報告書內容為、新興BRICSS各國的心臟再同步治療設備市場為焦點、直接取材及文書檢索所取得的調查資料為基礎、今後的市場趨勢和推移的預測外、M&A及企業間協力□合作、產品發行賣、技術開發的策略展開展最新資訊的彙整。

第1章 觀點

  • 介紹
    • 心臟病學
    • 心臟的各種條件
      • 心臟內血流
      • 心功能不全
      • 心筋
      • 心膜
      • 心臟瓣膜
      • 先天性心臟缺陷
      • 血管障礙
      • 心臟發作(HF)
  • 心血管設備
  • 心臟再同步治療(CRT)
    • 臨床磁氣得心律管理設備的角色
      • 心律調整器的磁氣影響
      • 內建除顫器的磁氣影響
  • 心臟再同步治療設備 - 市場的策略
    • 中國
    • 印度
    • 巴西
    • 俄羅斯
    • 韓國
    • 南非

第2章 市場分析

  • 心臟再同步治療設備 - 分類
    • 心臟再同步治療設備 - 形式分類
    • 心臟再同步治療設備 - BRICSS各國
  • 成長率分析
  • 投資的焦點

第3章 產業概要

  • 心臟用醫療機器的形式展望
    • 心律管理設備
    • 除顫器
    • 心律調整器
    • 心臟再同步治療(CRT)
    • 心臟監測□診斷設備
    • 侵襲性心臟設備
    • 末梢血管設備
    • 動靜脈連結血栓切除設備
    • 人工心臟瓣膜
  • 心臟用設備:死亡風險和年齡
  • 心臟疾病:經濟的觀點
    • 心血管疾病的經濟成本
    • 2030年心血管疾病的費用變成3倍
    • 心血管疾病幾乎可以預防
  • 非洲等感染性及心血管疾病
  • 心血管機器的美國食品藥物管理局(FDA)的最新措施及認定
  • 市場趨勢
  • 主要企業介紹
    • 其他企業的產業活動、產品發行
    • 心臟機器:市場銷售□開發中的產品
    • 心臟醫療機器 - 專利
    • 主要企業財務概況

第4章 業界企業資料庫

第5章 附錄

  • 調查的焦點
  • 關於AXIS RESEARCH MIND
  • 免責事項
  • 回饋
目錄
Product Code: ARMMR141N.1

“Getting the Most from Our Research Analysis”

BRICSS Cardiac Resynchronization Therapy (CRT) Devices market value is expected to reach US$455 million by 2016, primarily supported by the product types - Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Cardiac Resynchronization Pacemakers (CRT-P). China accounts for nearly 25% of the market share and India claims more than 23%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, Cardiac Resynchronization Therapy Defibrillator (CRT-D) accounts more nearly half of the market value while Cardiac Resynchronization Pacemakers (CRT-P) segments add up to the remaining half. Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

BRICSS CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - MARKET SHARE
BY TYPE - 2015-%

SEGMENTATION - By TYPE

  • CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
  • CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P)

REPORT FOCUS

“Learn High Potential Market Dynamics for Strategic Business Planning”

The report ‘Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.

The report focuses on the current market trends, estimates and forecasts for the period 2012-2018. More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 103 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

KEY COMPANIES PROFILED

ABBOTT VASCULAR DEVICES, ACCELLENT, INC., AEROTEL MEDICAL SYSTEMS, LTD., ANGIODYNAMICS, INC., ASAHI INTECC CO., LTD., ASAHI KASEI CORPORATION, BERLIN HEART GMBH, BIOHEART, INC., BIOSENSORS INTERNATIONAL GROUP, LTD., BIOTRONIK GMBH & CO. KG., BOSTON SCIENTIFIC CORPORATION, C. R. BARD, INC., CAMBRIDGE HEART, INC., CARDIOCOMM SOLUTIONS, INC., CARDIOROBOTICS, INC., COOK GROUP INCORPORATED, DRÄGER MEDICAL AG & CO. KG, ESAOTE S.P.A, FUDAN UNIVERSITY ZHONGSHAN HOSPITAL, GE HEALTHCARE, HEARTWARE LTD., INDRAPRASTHA APOLLO HOSPITAL, ITGI MEDICAL LTD., MEDTRONIC, INC., MERIT MEDICAL SYSTEMS, INC., MOLECULAR DEVICES, LLC, NIHON KOHDEN CORPORATION, SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD., SORIN GROUP USA, INC., SPECTRANETICS INTERNATIONAL B.V, ST. JUDE MEDICAL, USCOME LIMITED and many more...

GEOGRAPHIC COVERAGE

The region-wise distribution consists of Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea) analyzed individually.

Table of Contents

I. REPORT FOCUS

  • A. INTRODUCTION
  • CARDIOLOGY
  • KINDS OF CARDIAC CONDITIONS
  • A. BLOOD FLOW IN THE HEART
  • B. HEART MALFUNCTION
  • TYPES OF CARDIAC ARREST
  • C. MYOCARDIUM
  • DISORDERS OF MYOCARDIUM
  • D. PERICARDIUM
  • E. HEART VALVES
  • DISORDERS OF HEART VALVES
  • F. CONGENITAL HEART DEFECT
  • TYPES OF CONGENITAL HEART DEFECT
  • G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)
  • H. HEART FAILURE
  • B. CARDIOVASCULAR DEVICES
  • DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
  • TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
  • TOOLS DEPLOYED IN CARDIOLOGY
  • DIAGNOSTIC TESTS AND PROCEDURES
  • CONCLUSION
  • C. CARDIAC RESYNCHRONIZATION THERAPY (CRT)
  • ROLE OF CARDIAC RHYTHM MANAGEMENT DEVICES IN CLINICAL MAGNETS
  • PRECAUTIONS AGAINST CLINICAL MAGNET USE

1. EFFECT OF MAGNETS ON PACEMAKERS

  • KEY COMPANIES EXPLAINED BELOW
  • BOSTON SCIENTIFIC
  • MEDTRONIC
  • ST. JUDE MEDICAL
  • BIOTRONIK
  • SORIN

2. MAGNET EFFECTS ON IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

  • KEY COMPANIES EXPLAINED BELOW
  • BOSTON SCIENTIFIC
  • MEDTRONIC
  • ST. JUDE MEDICAL, BIOTRONIK AND SORIN
  • FUTURE CONSIDERATIONS
  • CONCLUSION
  • D. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - MARKET BRIEFING
  • CHINA
  • INDIA
  • BRAZIL
  • RUSSIA
  • SOUTH KOREA
  • SOUTH AFRICA

II. MARKET ANALYSIS

  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - BRICSS - INDUSTRY SNAPSHOT
  • A. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - SEGMENTATION
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - GLOBAL
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - BRICSS
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - BY TYPE
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - BRICSS
  • CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
  • CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P)
  • B. GROWTH RATE ANALYSIS
  • BRICSS CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - MARKET GROWTH RATES
  • BRICSS CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - GROWTH RATES
  • C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

  • FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
  • AN ENCOURAGING JAB FOR TORPID PERIODS
  • A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
  • CARDIAC RHYTHM MANAGEMENT DEVICES
  • CRM IN EUROPE
  • CARDIAC DEFIBRILLATORS
  • RAPID GROWTH IN DEFIBRILLATOR SALES
  • CARDIAC PACEMAKER DEVICES
  • THE DATA COLLECTION WORK
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT)
  • CARDIAC MONITORING AND DIAGNOSTIC DEVICES
  • THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
  • INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
  • THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW
  • INTERVENTIONAL CARDIAC DEVICES
  • CORONARY STENTS
  • EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION
  • FFR IMPACT ON DES MARKET
  • MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET
  • CARDIAC CATHETERS
  • COMPETITIVE ANALYSIS
  • ELECTROPHYSIOLOGY CATHETERS (EP)
  • GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
  • DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH
  • EP MAPPING
  • NEW AF ABLATION DEVICES SEEK APPROVAL
  • ATRIAL FIBRILLATION (AF)
  • INTRAVASCULAR ULTRASOUND (IVUS)
  • GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS
  • PERIPHERAL VASCULAR DEVICES
  • ARTERIOTOMY CLOSURE DEVICES
  • EMBOLIC PROTECTION DEVICES (EPD)
  • INFERIOR VENA CAVA (IVC) FILTERS
  • CONCLUSION
  • PERIPHERAL GUIDEWIRES
  • AV ACCESS THROMBECTOMY DEVICES
  • PROSTHETIC HEART VALVES
  • SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
  • MARKET CHALLENGES
  • B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
  • DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
  • SIZE AND WEIGHT
  • POWER EFFICIENCY
  • PERFORMANCE SPECIFICATIONS
  • RISK MITIGATION AND RELIABILITY
  • EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES
  • C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
  • CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
  • IMPACT OF CVD IN EUROPE
  • IMPACT ON NEW YORK STATE
  • ECONOMIC IMPACT OF CVD IN NYS
  • HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
  • IMPACT OF CVD ON ECONOMIC STABILITY
  • ECONOMIC COST OF CARDIOVASCULAR DISEASES
  • COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030
  • CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE
  • D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND
  • E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES
  • F. MARKET TRENDS
  • PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
  • CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
  • GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
  • GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
  • CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
  • INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
  • TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
  • INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
  • STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
  • GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
  • MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
  • B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
  • MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
  • RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
  • A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
  • ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
  • SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
  • FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER.
  • AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
  • SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
  • USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
  • MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN.
  • MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
  • DRUG-ELUTING STENTS ARE SECURE
  • CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
  • ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
  • ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
  • ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
  • BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.
  • HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
  • FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
  • FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”
  • BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
  • COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
  • MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
  • MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
  • NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY-INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
  • FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
  • STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
  • USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
  • SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
  • TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
  • CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
  • SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
  • EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
  • ZOLL NOMINATED TO GLOBE 100 AGAIN
  • USCOM ENTERS EUROPEAN MARKETS
  • POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
  • USCOM SECURES STRONG PRESENCE IN US AND CANADA
  • CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
  • COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
  • STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
  • SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT
  • CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
  • USCOM EYES EASTERN EUROPEAN MARKET
  • VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
  • INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
  • INFECTIONS FROM IMPLANTED CARDIAC DEVICES
  • TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
  • HEART TRANSPLANTS SUBSTITUTED BY A PUMP
  • DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
  • REMOTE MONITORING OF HEART FAILURE PATIENTS
  • EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
  • OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
  • IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
  • OVER-THE-COUNTER APPARATUS
  • BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR
  • CARDIAC SCIENCE'S NEW CARDIAC TREATMENT
  • THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
  • CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
  • LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
  • A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
  • A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
  • LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
  • INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
  • BEST AND LATEST SELF-TEACHING HEART SOUNDS
  • REPLACING VALVE WITHOUT CARDIAC SUPPORT
  • U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
  • AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
  • NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
  • MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS
  • G. KEY COMPANY PROFILES
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD
  • OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES
  • CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • CARDIAC MEDICAL DEVICES - PATENTS
  • KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX

  • RESEARCH FOCUS
  • ABOUT AXIS RESEARCH MIND
  • DISCLAIMER
  • FEEDBACK

LIST OF TABLES/CHARTS

I. REPORT FOCUS

  • D. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - MARKET BRIEFING
  • CHINA
  • 1. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) FOR CHINA - (2012-2018, IN USD$ MILLION)
  • 2. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - % OF CHINESE MARKET VALUE - (2015 - 2018)
  • INDIA
  • 3. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) FOR INDIA - (2012-2018, IN USD$ MILLION)
  • 4. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - % OF INDIAN MARKET VALUE - (2015 - 2018)
  • BRAZIL
  • 5. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) FOR BRAZIL - (2012-2018, IN USD$ MILLION)
  • 6. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - % OF BRAZILIAN MARKET VALUE - (2015 - 2018)
  • RUSSIA
  • 7. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) FOR RUSSIA - (2012-2018, IN USD$ MILLION)
  • 8. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - % OF RUSSIAN MARKET VALUE - (2015 - 2018)
  • SOUTH KOREA
  • 9. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) FOR SOUTH KOREA - (2012-2018, IN USD$ MILLION)
  • 10. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)
  • SOUTH AFRICA
  • 11. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) FOR SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 12. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - % OF SOUTH AFRICAN - (2015 - 2018)
  • 13. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - PRODUCT BY BRANDS

II. MARKET ANALYSIS

  • 14. BRICSS CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - SEGMENTATION BY TYPES
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - GLOBAL
  • 15. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - BRICSS
  • 16. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 17. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 18. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - BY TYPE
  • 19. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) FOR BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 20. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - % OF BRICSS MARKET VALUE - (2015-2018)
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - BRICSS
  • CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
  • 21. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 22. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P)
  • 23. CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 24. CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)
  • B. GROWTH RATE ANALYSIS
  • BRICSS CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - MARKET GROWTH RATES
  • 25. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET - BRICSS- % GROWTH RATE FORECASTS - (2012-2018)
  • BRICSS CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - GROWTH RATES
  • 26. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES - % GROWTH RATE FORECASTS FOR CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - (2012-2018)
  • C. INVESTMENT FOCUS
  • 27. CARDIAC RESYNCHRONIZATION THERAPY (CRT) - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
  • 28. CARDIAC RESYNCHRONIZATION THERAPY (CRT) - TYPES - CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P) - FORECASTED CAGR% - VALUE - 2012 -2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL

III. INDUSTRY OVERVIEW

  • 29. INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 30. INTRAVENOUS DIAGNOSTICS - BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 31. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)
  • 32. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)
  • 33. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)
  • 34. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES
  • 35. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 36. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 37. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014
  • 38. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013
  • 39. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
  • 40. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • 41. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 42. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014
  • 43. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 44. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)
  • 45. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ '000)
  • 46. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ '000)
  • 47. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
  • 48. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN DKK MILLION)
  • 49. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ '000)
  • 50. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC & INTERNATIONAL AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
  • 51. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ MILLION)
  • 52. BECTON, DICKINSON & CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)
  • 53. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ '000)
  • 54. BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
  • 55. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ '000)
  • 56. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)
  • 57. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 58. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ '000)
  • 59. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD
  • 60. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT & GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 61. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)
  • 62. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 63. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 64. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 65. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
  • 66. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 67. DRÄGER MEDICAL AG & CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ 'MILLION)
  • 68. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ 'MILLION)
  • 69. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 70. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 71. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 72. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)
  • 73. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ '000)
  • 74. JOHNSON & JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 75. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)
  • 76. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ '000)
  • 77. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)
  • 78. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB'000)
  • 79. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)
  • 80. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)
  • 81. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)
  • 82. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 83. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 84. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 85. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 86. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 87. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)
  • 88. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 89. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 90. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 91. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)
  • 92. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ '000)
  • 93. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)
  • 94. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 95. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 & 2012 (IN USD)
  • 96. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)
  • 97. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO '000)
  • 98. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)
  • 99. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)
  • 100. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)
  • 101. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)
  • 102. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)
  • 103. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN ‘¥' YEN)

KEY COMPANY PROFILES

NORTH AMERICA

  • ALERE, INC.
  • CARDIOROBOTICS, INC.
  • INTERFACE BIOLOGICS, INC.
  • MERIDIAN HEALTH SYSTEM, INC
  • CARDIVA MEDICAL, INC.
  • LOMBARD MEDICAL TECHNOLOGIES PLC
  • DELTEX MEDICAL GROUP PLC
  • BIOTELEMETRY, INC.
  • BIOHEART, INC.
  • ASAHI INTECC CO., LTD.
  • ANGIODYNAMICS, INC.
  • MERIT MEDICAL SYSTEMS, INC.
  • MOLECULAR DEVICES, LLC
  • ACCELLENT, INC.
  • MEDTRONIC, INC.
  • ABBOTT VASCULAR DEVICES
  • CAMBRIDGE HEART, INC.
  • GREATBATCH, INC.
  • ABIOMED, INC.
  • ADVANSOURCE BIOMATERIALS CORPORATION
  • ATRICURE, INC.
  • ATRIUM MEDICAL CORPORATION
  • BIOPHAN TECHNOLOGIES, INC.
  • BIOSENSE WEBSTER, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • CARDIAC SCIENCE CORPORATION
  • CARDIACASSIST, INC.
  • CARDICA, INC.
  • COOK GROUP INCORPORATED
  • CORDIS CORPORATION
  • CRYOLIFE INC.
  • MAQUET GMBH & CO. KG
  • DIGIRAD CORPORATION
  • EDWARDS LIFESCIENCES, LLC.
  • ENDOLOGIX INCORPORATED
  • ISSYS SENSING SYSTEMS, INC
  • APTUS ENDOSYSTEMS, INC.
  • FLUXION
  • JOHNSON & JOHNSON
  • KONINKLIJKEDSM N.V.
  • MEDRAD, INC.
  • BIOCLINICA
  • MILLAR INSTRUMENTS, INC
  • MONEBO TECHNOLOGIES, INC.
  • MORTARA INSTRUMENT, INC.
  • SIEMENS MEDICAL SOLUTIONS USA, INC.
  • SONOSITE, INC.
  • SORIN GROUP USA, INC.
  • ST. JUDE MEDICAL
  • STEREOTAXIS, INC.
  • TELEFLEX, INC.
  • CARDIOVASCULARSYSTEMS, INC.
  • TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
  • TERUMO HEART, INC.
  • THORATEC CORPORATION
  • VICOR TECHNOLOGIES, INC.
  • VOLCANO CORPORATION
  • COMPUMED, INC.
  • PULSION MEDICAL SYSTEMS SE
  • 3M HEALTHCARE
  • BAXTER INTERNATIONAL INC.
  • BECTON, DICKINSON & CO.
  • NOVADAQ TECHNOLOGIES INC.
  • SCOTTCARE CARDIOVASCULAR SOLUTIONS
  • VARIAN MEDICAL SYSTEMS, INC.
  • THERMEDICS, INC.
  • LEVITRONIX, LLC
  • SUNSHINE HEART, INC.
  • ACCUTECH, LLC
  • ASH ACCESS TECHNOLOGY, INC.
  • C. R. BARD, INC.
  • CONMED CORPORATION
  • HOSPIRA, INC.
  • SURGICAL SPECIALISTIES CORPORATION
  • CARDIUM THERAPEUTICS, INC.
  • CIRCULITE, INC.
  • CARDIOCOMM SOLUTIONS, INC.

EUROPE

  • BERLIN HEART GMBH
  • ESAOTE S.P.A
  • SOPHION BIOSCIENCE A/S
  • BIOTRONIK GMBH & CO. KG.
  • DRÄGER MEDICAL AG & CO. KG
  • BIOTEQUE CORPORATION
  • SPECTRANETICS INTERNATIONAL B.V
  • AORTECH INTERNATIONAL, PLC.
  • APC CARDIOVASCULAR, LTD.
  • ARTERIAL REMODELING TECHNOLOGIES
  • GE HEALTHCARE
  • LIDCO GROUP PLC
  • PHILIPS MEDICAL SYSTEMS
  • SMITH & NEPHEW PLC
  • VASCULAR CONCEPTS
  • AMBU A/S
  • FLEMING MEDICAL LIMITED
  • COVIDIEN PLC

ASIA-PACIFIC

  • NIHON KOHDEN CORPORATION
  • ALL PRO CORPORATION
  • FUKUDA DENSHI CO., LTD.
  • SICHUAN JINJIANG ELECTRONIC SCIENCE AND TECHNOLOGY CO., LTD
  • SYNCARDIA SYSTEMS, INC.
  • MICROPORTS MEDICAL
  • LEPU MEDICAL
  • BEIJING ANZHEN HOSPITAL
  • FUDAN UNIVERSITY ZHONGSHAN HOSPITAL
  • INDRAPRASTHA APOLLO HOSPITAL
  • SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD.
  • OPTO CIRCUITS INDIA LIMITED
  • ASAHI KASEI CORPORATION
  • ASIAN HEART INSTITUTE
  • NARAYANA HRUDAYALAYA
  • USCOME LIMITED
  • HEARTWARE LTD.
  • BIOSENSORS INTERNATIONAL GROUP, LTD.
  • ATCOR MEDICAL HOLDINGS LIMITED
  • CATHRX LTD
  • TTK HEALTHCARE
  • GOODMAN CO., LTD.

REST OF WORLD

  • INSPIREMD LTD.
  • ITGI MEDICAL LTD.
  • MEDINOL, LTD.
  • GAMIDA CELL LTD.
  • AEROTEL MEDICAL SYSTEMS, LTD.
Back to Top